Citation Impact
Citing Papers
The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti–HER-2 Therapy and Personalized Medicine
2009
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
2012 Standout
Estrogen Receptor Status by Immunohistochemistry Is Superior to the Ligand-Binding Assay for Predicting Response to Adjuvant Endocrine Therapy in Breast Cancer
1999 Standout
Untangling the ErbB signalling network
2001 Standout
HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas.
1997
Plasma c-erbB-2 levels in breast cancer patients: prognostic significance in predicting response to chemotherapy.
1998
The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers-A review
1995
Targeted Therapy in Breast Cancer
2004
Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers
2010
Multinational Study of the Efficacy and Safety of Humanized Anti-HER2 Monoclonal Antibody in Women Who Have HER2-Overexpressing Metastatic Breast Cancer That Has Progressed After Chemotherapy for Metastatic Disease
1999 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials
2011 Standout
Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots
2002 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
The implications of angiogenesis for the biology and therapy of cancer metastasis
1994 Standout
The mechanisms of Hedgehog signalling and its roles in development and disease
2013 Standout
Lymphangiogenesis and cancer metastasis
2002 Standout
Expression of bcl-2 Oncoprotein in Benign and Malignant Spindle Cell Tumors of Soft Tissue, Skin, Serosal Surfaces, and Gastrointestinal Tract
1998
Clinical translation of angiogenesis inhibitors
2002 Standout
Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis
1996 Standout
Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis
2001 Standout
Prognostic significance of HER-2/neu oncoprotein expression in node-positive breast cancer. The influence of the pattern of immunostaining and adjuvant therapy
1994
Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy
2012 Standout
Plasma Homocysteine as a Risk Factor for Dementia and Alzheimer's Disease
2002 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Angiosarcomas Express Mixed Endothelial Phenotypes of Blood and Lymphatic Capillaries
1999 Standout
Molecular characterisation of soft tissue tumours: a gene expression study
2002 Standout
Lymphangiogenesis: Molecular Mechanisms and Future Promise
2010 Standout
Head and neck cancer
2008 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Function and Regulation of CREB Family Transcription Factors in the Nervous System
2002 Standout
An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype
2002 Standout
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Essential role for oncogenic Ras in tumour maintenance
1999 Nature
EGF–ERBB signalling: towards the systems level
2006 Standout
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
1994 Standout
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
CD34 immunoexpression in stromal tumours of the gastrointestinal tract and in mesenteric fibromatoses
1994
Neuronal death and survival in two models of hypoxic-ischemic brain damage
1999
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
p53 in health and disease
2007 Standout
VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment
2004 Standout
Estrogen and progesterone receptor status determined by the Ventana ES 320 automated immunohistochemical stainer and the CAS 200 image analyzer in 236 early-stage breast carcinomas: Prognostic significance
1996
Live or let die: the cell's response to p53
2002 Standout
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma
2004
The p53 family in nervous system development and disease
2006
Angiogenesis in cancer, vascular, rheumatoid and other disease
1995 Standout
Quantitative immunohistochemical analysis of transforming growth factor-α and epidermal growth factor receptor in patients with squamous cell carcinoma of the head and neck
1996
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 Standout
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
2011 Standout
CD34 expression by gastrointestinal tract stromal tumors
1994
Platinum-Based Chemotherapy plus Cetuximab in Head and Neck Cancer
2008 Standout
Levels of TGF-α and EGFR Protein in Head and Neck Squamous Cell Carcinoma and Patient Survival
1998 Standout
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Breast cancer metastasis: markers and models
2005 Standout
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Head and Neck Cancer
2001 Standout
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Cardiac Dysfunction in the Trastuzumab Clinical Trials Experience
2002 Standout
APAF1 is a key transcriptional target for p53 in the regulation of neuronal cell death
2001
Expression of endothelial cell adhesion molecules on heart valves: up-regulation in degeneration as well as acute endocarditis
2000
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
1998 StandoutScience
Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors
1999
The HER-2/neu Gene and Protein in Breast Cancer 2003: Biomarker and Target of Therapy
2003
Role of HER2 gene overexpression in breast carcinoma
2000
Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules
1996
Efficacy and Safety of Trastuzumab as a Single Agent in First-Line Treatment of HER2-Overexpressing Metastatic Breast Cancer
2002 Standout
Homocysteine Elicits a DNA Damage Response in Neurons That Promotes Apoptosis and Hypersensitivity to Excitotoxicity
2000
Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.
1993
The HER‐2/ neu Oncogene in Breast Cancer: Prognostic Factor, Predictive Factor, and Target for Therapy
1998
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Works of Parula Mehta being referenced
Immunohistochemical assay of neu/c-erbB-2 oncogene product in paraffin-embedded tissues in early breast cancer: retrospective follow-up study of 245 stage I and II cases.
1991
Nuclear accumulation of p53 protein following kainic acid-induced seizures
1996
Biologic Significance of Quantitative Estrogen Receptor Immunohistochemical Assay by Image Analysis in Breast Cancer
1994
Vimentin-Negative Epithelioid Sarcoma
1993
Improvement of the Quantification of Estrogen and Progesterone Receptors in Paraffin-Embedded Tumors by Image Analysis
1993
Immune electron microscopic characterization of monoclonal antibodies to Alzheimer neurofibrillary tangles.
1992
The Human Hematopoietic Progenitor Cell Antigen (CD 3 4) in Vascular Neoplasia
1991